Condition: Squamous Cell Carcinoma
Interventions: Drug: Levulan Kerastick; Device: blue light source; Other: participant satisfaction survey
Sponsors: Rhode Island Hospital; DUSA Pharmaceuticals, Inc.
Not yet recruiting - verified December 2016
http://ift.tt/2jCvbmR
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου